CTLA-4 suppresses dendritic cell maturation and function by activating the extracellular signal–regulated kinase (ERK; encoded by MAPK1) and STAT3 pathways, which impairs T cell activation and anti-tumor immunity. The gene discussed is MAPK1; the disease is neoplasm.